For citations:
Gayda A.I., Abramchenko A.V., Romanova M.I., Toichkina T.V., Burykhin V.S., Borisov S.E., Filippov A.V., Kuznetsova T.A., Perkhin D.V., Sveshnikova O.M., Lekhlyayder M.V., Panteleev A.M., Toinova S.V., Maslennikova T.I., Galakhova D.O., Populyashina L.N., Saenko G.I., Anisimova E.S., Svicharskaya A.K., Sosova N.A., Lovacheva O.V., Maryandyshev A.O., Samoylova A.G. Justification of Chemotherapy Duration in Patients with Multiple and Pre-Extensive Drug Resistant Tuberculosis in the Russian Federation. Tuberculosis and Lung Diseases. 2022;100(12):44-53. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-12-44-53
Email this article 